Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Subscribe
Home
Promote Your Event
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Local Weather
News
Local News
Sports
Entertainment
Obituaries
Local Events
Photos
Videos
e-Edition
Classifieds
Place an ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Bioventus, Inc.
Bioventus Completes Divestiture of its Wound Business
May 23, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports First Quarter Financial Results
May 16, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
May 15, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
May 11, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Announces Divestiture of its Wound Business
May 10, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
May 03, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Announces CEO Leadership Change
April 05, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
March 31, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
March 31, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
March 29, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
March 16, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition
February 28, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
November 21, 2022
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022
November 16, 2022
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
November 08, 2022
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
October 31, 2022
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
October 12, 2022
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.